Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial

Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial

Background/purpose: Roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor, promotes erythropoiesis and regulates iron metabolism. This study investigated the efficacy and safety of roxadustat in Chinese patients with anemia on peritoneal dialysis (PD). Methods: One hundr...

Full description

Bibliographic Details
Main Authors:	Yan-Pei Hou, Xin-Yue Mao, Chang Wang, Zhi-Hui Xu, Zhi-Hua Bu, Meng Xu, Bing Li
Format:	Article
Language:	English
Published:	Elsevier 2022-02-01
Series:	Journal of the Formosan Medical Association
Subjects:	Anemia Chronic kidney disease Clinical trial Peritoneal dialysis Roxadustat
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664621002503

Similar Items

Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis
by: Tong Wu, et al.
Published: (2022-12-01)

A retrospective study on the efficacy of Roxadustat in peritoneal dialysis patients with erythropoietin hyporesponsiveness
by: Jie Liu, et al.
Published: (2024-05-01)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
by: Keiji Hirai, et al.
Published: (2021-07-01)

Evaluating the effect of Roxadustat on ventricular repolarization in patients undergoing peritoneal dialysis
by: Yangyang Zhang, et al.
Published: (2023-10-01)

The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
by: Qiaoqiao Zhou, et al.
Published: (2023-12-01)

Efficacy and safety of roxadustat for the treatment of anemia in non-dialysis chronic kidney disease patients: A systematic review and meta-analysis of randomized double-blind controlled clinical trials
by: Ting Chen, et al.
Published: (2022-11-01)

Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
by: Yaling Zhang, et al.
Published: (2021-01-01)

Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis
by: Chao Liu, et al.
Published: (2021-08-01)

A nomogram for predicting the risk of treatment failure of roxadustat in peritoneal dialysis with renal anemia
by: Jiangqing Fan, et al.
Published: (2024-04-01)

The role of roxadustat in chronic kidney disease patients complicated with anemia
by: Jie Liu, et al.
Published: (2023-03-01)

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis
by: Shuiqin Cheng, et al.
Published: (2023-06-01)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
by: Keiji Hirai, et al.
Published: (2023-02-01)

Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
by: Xiaoxiao Tang, et al.
Published: (2023-11-01)

Roxadustat on Renal Anemia with Macroinflammation: A Retrospective Cohort Study
by: Yan Tu, et al.
Published: (2024-03-01)

Roxadustat: Not just for anemia
by: Xiaoyu Zhu, et al.
Published: (2022-08-01)

Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis
by: Shan Chong, et al.
Published: (2022-09-01)

Influencing factors of clinical efficacy of roxadustat among hemodialysis patients
by: Wenhui Wu, et al.
Published: (2024-12-01)

Roxadustat regulates iron metabolism in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A meta-analysis
by: Yan-Pei Hou, et al.
Published: (2022-11-01)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
by: Xiaomeng Zheng, et al.
Published: (2023-12-01)

Research progress on roxadustat treatment for renal anemia
by: HU Bao-li, HU Bin
Published: (2022-09-01)

The Efficacy and Safety of Roxadustat for Anemia in Hemodialysis Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials
by: Yunling Geng, et al.
Published: (2024-11-01)

The Efficacy and Safety of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis
by: Lijun Wang, et al.
Published: (2022-04-01)

Cardiovascular Protective Effects of Oral Hypoxia Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat in the Treatment of Type 4 Cardiorenal-Anemia Syndrome: Protocol of a Randomized Controlled Trial
by: Yumin Wen, et al.
Published: (2022-04-01)

Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients
by: Ya-Hui Yang, et al.
Published: (2023-12-01)

Case report: Roxadustat overdose in an anemia patient of chronic kidney disease: insight beyond insignificant consequence
by: Long-Guang Zhang, et al.
Published: (2024-08-01)

Impact of C-reactive protein on the effect of Roxadustat for the treatment of anemia in chronic kidney disease: a systematic review of randomized controlled trials
by: Xiaoyu Luo, et al.
Published: (2024-02-01)

Roxadustat: Do we know all the answers?
by: Qiu-Yu Li, et al.
Published: (2023-05-01)

Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis
by: Lei Tian, et al.
Published: (2024-12-01)

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
by: Huang JY, et al.
Published: (2016-11-01)

Budget impact analysis on the Italian healthcare system of roxadustat for the treatment of anemia due to chronic kidney disease
by: Chiara Bini, et al.
Published: (2024-09-01)

Association between anemia-related biomarkers and the adequacy of peritoneal dialysis in Chinese patients with chronic kidney disease
by: Jia-Lin Li, et al.
Published: (2023-07-01)

Factors influencing occurrence of peritonitis in Saudi children on peritoneal dialysis
by: Khamisa Al Mokali, et al.
Published: (2020-01-01)

Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study
by: Xuejie Zhang, et al.
Published: (2023-11-01)

Resorption and tolerance of the high doses of ferrous sulfate and ferrous gluconate in the patients on peritoneal dialysis
by: Laušević Mirjana, et al.
Published: (2006-01-01)

Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
by: Mei Tang, et al.
Published: (2021-07-01)

Comparative iron management in hemodialysis and peritoneal dialysis patients: a systematic review
by: Thomas S. van Lieshout, et al.
Published: (2024-11-01)

Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization
by: Rong Dai, et al.
Published: (2023-09-01)

Percutaneous insertion of peritoneal dialysis catheters by the nephrologist (modified Seldinger technique)
by: Karlien Francois, et al.
Published: (2021-12-01)

Low serum vitamin D concentration is correlated with anemia, microinflammation, and oxidative stress in patients with peritoneal dialysis
by: Chi Zhang, et al.
Published: (2021-09-01)

A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
by: Zhipeng Yan, et al.
Published: (2020-08-01)